Featured News

ActoBio announces FDA has given permission to an Investigational New Drug (IND) application for Actobiotics® AG017, a therapeutic candidate for celiac disease.

Whether you’re asking for yourself, a loved one or for a friend, here are the answers to the most common questions that come up after a diagnosis of celiac disease or gluten sensitivity.

Underscoring its role as a leader in online tools for the gluten-free community, Celiac Disease Foundation (CDF) today launched the Gluten-Free Allergy-Free Marketplace, a new retail destination hosted on celiac.org. Featured at celiac.org/marketplace, the Marketplace showcases products and services from companies that care about the gluten-free and allergy-free community, and have made a deep commitment to supporting CDF’s mission of diagnosis, treatment, and a cure for celiac disease.